ACTG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ACTG is not a good buy right now for a Beginner long-term investor with $50,000-$100,000 to deploy. The stock has support from a strong cash position and a bullish analyst target revision, but the latest quarter showed weaker operating performance, the technical trend is short-term bearish, and there is no strong proprietary buy signal today. Based on the current setup, I would not buy aggressively at this level; I would wait for either better fundamentals or a cleaner technical entry.
The chart is mixed to bearish in the near term. MACD histogram is below zero and expanding negatively, which points to weakening momentum. RSI_6 at 22.93 suggests the stock is oversold, but not yet a strong reversal confirmation by itself. Moving averages are still constructive with SMA_5 > SMA_20 > SMA_200, so the broader trend is not broken. Price is currently below the pivot (4.925) and closer to support at S1 (4.635), with further support at S2 (4.456). Overall, the short-term trend is weak even though the long-term structure is not fully damaged.
The biggest positive catalyst is the company’s large cash and securities balance of $330 million as of March 31, 2026, which gives it flexibility for growth and project investment. Management also expects more than a 2.5x return on the Cherokee well project, and analysts noted potential production growth of around 10% from the first Cherokee oil well with possible additional wells this year. Craig-Hallum raised its price target to $6 from $5 and kept a Buy rating, suggesting upside from the current price.
Q1 2026 revenue declined to $54.2 million and the company posted a GAAP operating loss of $8.4 million, showing weaker current operating performance. Management also flagged tariff pressure and macroeconomic uncertainty as risks that could delay customer purchases and hurt revenue and profitability. The stock fell sharply in the latest session, and the near-term technical picture remains weak. No recent insider buying, hedge-fund accumulation, or congress trading support is visible.
Latest quarter: Q1 2026. Revenue was $54.2 million, down year over year, while the company reported a GAAP operating loss of $8.4 million. The balance sheet remains strong with $330 million in cash and securities. In the prior reported quarter, Q4 2025 revenue increased 2.63% YoY to 50.13 million, but net income fell 125.45% YoY to $3.42 million, EPS dropped 128.57% YoY to $0.04, and gross margin contracted to 16.38%. Growth is uneven and profitability has weakened.
Analyst sentiment is moderately positive. Craig-Hallum raised its price target to $6 from $5 and reiterated a Buy rating, noting ACTG trades below diluted book value and that end markets remain mixed. The pros view is that the stock may be undervalued and supported by asset value and project upside. The cons view is that operating conditions are mixed, recent financial results are weak, and the market is not yet rewarding the story with strong price action.
